ACTRIMS 2023: Less frequent Ocrevus infusion not tied to greater MS activity | Analysis of changes made during COVID-19
Greater disease activity was not evident in MS patients given a next Ocrevus infusion at times beyond the recommended every six months.
Source: multiplesclerosisnewstoday.com